• Product NameRecombinant Human CSGALNACT2
• Brief DescriptionRecombinant Protein
• Immunogen DescriptionFusion protein corresponding to C terminal 250 amino acids of human chondroitin sulfate N-acetylgalactosaminyltransferase 2
• Target Namechondroitin sulfate N-acetylgalactosaminyltransferase 2
• Alternative Names    CHGN2; PRO0082; GALNACT2; GALNACT-2
• Accession No. Swissprot:Q8N6G5
  Gene Accession:BC030268
• UniprotQ8N6G5
• Gene ID55454;
• Storage -20~-80˚C, pH 7.6 PBS

This gene encodes a member of the chondroitin N-acetylgalactosaminyltransferase family. The encoded protein is involved in elongation during chondroitin sulfate synthesis. A related pseudogene has been identified on chromosome X. Transfers 1,4-N-acetylgalactosamine (GalNAc) from UDP-GalNAc to the non-reducing end of glucuronic acid (GlcUA). Required for addition of the first GalNAc to the core tetrasaccharide linker and for elongation of chondroitin chains.

Note: For in vitro research use only, not for diagnostic or therapeutic use. This product is not a medical device.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting